Just heard on the news , 2017-2018. , 2.2% drop in
Post# of 144919
![](/assets/46931549/no_avatar_available_thumb.jpg)
In Europe statistics not as good since there is limitation in treatment ..
With all the improvement we see in USA still more cases and death in breast , colorectal and prostate cancer .
Hopefully with help of Leronlimab statistics with those cancers will also improve very soon ..
Let’s get some more patients and approval within months and not years !!
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)